Understanding female sexual dysfunction, its causes and treatments

2021 ◽  
Vol 30 (18) ◽  
pp. S18-S29
Author(s):  
Angela Gregory

Female sexual dysfunction can greatly affect a woman's quality of life. Affected patients need a comprehensive assessment that includes taking a sexual history, medical evaluation and, if appropriate, a manual examination in order to diagnose, treat or identify factors relevant for each individual woman. There may be biological, psychological, emotional and relationship issues. Any biological factors such as vaginal dryness, pelvic floor dysfunction or chronic pain need to be addressed first to help prevent more complex problems developing. Sexual problems may be the cause of or the result of dysfunctional or unsatisfactory relationships. Psychological and emotional factors can create difficulties in sexual response and, equally, they can be the result of unaddressed or untreated biological/medical issues. Nurses working in urology need to be aware of the physiology involved in sexual response and know which conditions and illnesses are likely to affect sexual functioning and which treatments can help.

2021 ◽  
Vol 27 ◽  
Author(s):  
Konstantinos P. Imprialos ◽  
Konstantinos Koutsampasopoulos ◽  
Aleksandra Katsimardou ◽  
Sofia Bouloukou ◽  
Iakovos Theodoulidis ◽  
...  

Background: Female sexual dysfunction (FSD) has mainly been underdiagnosed and undertreated due to the lack of concrete definitions, validated assessment methods, and efficient treatments. However, during the last few decades, there has been significant progress in the clinical management and research of FSD. Objective: The purpose of this review is to describe the pathophysiology of FSD, report the prevalence of the disease in the setting of cardiovascular (CV) risk factors and disease, and review current and under investigation treatment options. Methods: A comprehensive literature review was performed to identify studies examining the association of FSD with CV risk factors and/or disease and studies reporting appropriate management options. Results: The prevalence of FSD is increased in the general population (approximately 40%) and is significantly higher in patients with hypertension, diabetes mellitus, and dyslipidemia. In patients with overt CV disease, FSD is even more prevalent (up to 90%). The cause of FSD is multifactorial and includes various vascular, hormonal, interpersonal, and psychological factors, which are all intertwined. Several treatment options exist that are efficient in improving female sexual function, while a cluster of other alternatives has been shown to offer benefits. Conclusion: FSD is a significant public health problem with a great impact on the patients’ quality of life. In the setting of increased CV burden, FSD is even more prevalent. Increased awareness is needed for the physician to establish a trustful environment with the patient, discuss such issues, and offer suitable management options.


Maturitas ◽  
2016 ◽  
Vol 94 ◽  
pp. 87-91 ◽  
Author(s):  
Prof. Rossella E. Nappi ◽  
Laura Cucinella ◽  
Silvia Martella ◽  
Margherita Rossi ◽  
Lara Tiranini ◽  
...  

Medicina ◽  
2019 ◽  
Vol 55 (6) ◽  
pp. 240
Author(s):  
Ivan Radoja ◽  
Dunja Degmečić

Background and objectives: Urinary incontinence is defined as the involuntary leakage of urine. Studies have reported that the severity of urinary incontinence symptoms can cause decreased quality of life and female sexual dysfunction in women, but the association between the duration of the incontinence and the aforementioned disturbances has not been evaluated. The objective of this study was to evaluate the differences in the occurrence of decreased quality of life and female sexual dysfunction in Croatian women with urinary incontinence, with regard to the duration and subtype of urinary incontinence. Materials and Methods: We conducted a cross-sectional study from March 2017 to July 2018 at our neurourology and urodynamics outpatient clinic, among 120 women with urinary incontinence symptoms. Based on medical history, physical exam and urodynamic assessment, participants were divided into groups with stress-, urgency- and mixed urinary incontinence. Several quality of life and female sexual dysfunction questionnaires were used for evaluation. The differences between the three UI groups were tested by the Kruskal–Wallis test. All p values were two-sided. The level of significance was set to Alpha = 0.05. Results: The mixed urinary incontinence group had a significantly inferior quality of life (p = 0.003) and lower scores on the female sexual dysfunction questionnaires (p = 0.02). The longer the duration of incontinence King’s Health Questionnaire total score was worse (p = 0.003) and Female Sexual Function Index total score was worse (p < 0.001). Conclusions: Our results showed that there was a statistically significant difference in the occurrence of decreased quality of life and female sexual dysfunction considering the duration and subtype of incontinence in Croatian women.


2010 ◽  
Author(s):  
Maziar Abdolrasulnia ◽  
Richard M. Shewchuk ◽  
Nancy Roepke ◽  
U. Shanette Granstaff ◽  
John Dean ◽  
...  

Author(s):  
Ganesh Adaikan

According to the World Health Organization, sexual health as a state of physical, emotional, mental, and social well-being in the context of sexuality, excludes the mere absence of disease, dysfunction, or infirmity. Thus a woman’s sexual function encompasses many areas; the construct of a normal function as a quality of life indicator often but not always conforms to the sexual response cycle, which is an endogenous process contributed by hormonal, vascular, neuronal, and psycho-emotional factors. Clinical and scientific evidence abounds about the physiological role of sex steroids viz. oestrogen, testosterone, and also progesterone in facilitating and maintaining the woman’s sexual parameters. The neurophysiology extends from the central and peripheral nervous systems to the targeted genital structures resulting in coordinated vascular and non-vascular smooth muscle relaxation, to be accompanied by pelvic vasocongestion, vaginal lubrication, and labial and clitoral engorgement. Any detrimental impact on this normal cycle of concerted responses can result in a functional impairment or ‘female sexual dysfunction’ (FSD). Sexual changes, psychogenic or organic, are common in women at any age; such complaints are frequently accompanied by quality-of-life concerns, varying levels of personal distress, anxiety, depression, and also fertility concerns in younger women. With FSD as a medically diagnosable entity, fewer drugs have met the safety and efficacy criteria for global approval and clinical utility. In order to appreciate the diverse range of FSD and the extent of its physical, physiological, and psychological implications, it is important to understand the fundamentals as well as the changing paradigms in a woman’s sexual functioning.


2020 ◽  
Vol 8 (2) ◽  
Author(s):  
Alaleh Asghari Roodsari ◽  
Afsaneh Khademi ◽  
Ehsan Akbari Hamed ◽  
Seideh Leila Tabatabaiifar ◽  
Ashraf Alleyassin

Background: Sexuality and its manifestation constitute some of the most complex of human behavior. Sexual dysfunction is more prevalent in women than in men. Prevalence of the subgroups of female sexual disorders is: desire disorder in 5-46%, arousal disorders in 7-10% and orgasmic disorders in 7- 10%. The objective of our study was to measure the prevalence of female sexual dysfunction in female medical students. Materials and Methods: Thirty two medical students participated in the study. The mean age was 24.30± 1.29 years. Duration of marriage was 2.68±1.5 years. Their husbands’ education ranges from secondary school diploma to PhD. Persian version of Sexual Function Questionnaire (SFQ) was piloted among medical students with and without chief complaint of female sexual dysfunction. Results: Prevalence of an abnormal score in each subgroup of SFQ was as follows: 20.0% in desire, 56.7% in arousal sensation, 33.3% in arousal lubrication, 36.7% in orgasm, 6.7% in pain and 20.0% in enjoyment. In our study 40.0% had sexual problems at least in one subgroup and 6.7% had problems in all subgroups. Only 2 participants were unsatisfied with their sexual life and seeking for any treatment. Discussion: In this study, prevalence of Female Sexual Dysfunction (FSD) ranges from 6.7% to 56.7% in subgroups of the disorder. Solving social problems have critical effect on quality of life. Evaluation of FSD is important in total and especially in women who are university educated and will be occupied in essential positions.


2020 ◽  
pp. 33-37
Author(s):  
O.I. Nehrych ◽  
◽  
V.I. Pyrohova ◽  

Despite a lot of studies of sexual dysfunction there are still no consistent data about the prevalence and characteristics of sexual dysfunction among women with MS, especially it terms of multiple sclerosis severity and duration. The objective: was to determine the prevalence of various SD symptoms among female MS patients, depending on the age and severity of the disease, and evaluate SD impact on quality of life. Materials and methods. The study population includes 116 female patients with MS (McDonald’s criteria, 2010). Health – related quality of life was measured by the Multiple Sclerosis Quality of Life Questionnaire (MSQOL-54). Sexual dysfunction was assessed with the Sexual Function Index for Women with Multiple Sclerosis Questionnaire. Results. A direct average correlation between satisfaction with sexual life and relationships; sexual activity and arousal; discomfort and pain during sexual intercourse; direct impact of multiple sclerosis on sexual life and total quality of life, physical health component, mental health component was established (р<0.05). The prevalence of sexual dysfunction increases with the age and disease duration. Conclusions. Our data confirm that SD is common symptom in women with MS and significantly affect their quality of life. Key words: multiple sclerosis, female sexual dysfunction.


2019 ◽  
Vol 1 (1) ◽  
pp. 52-56 ◽  
Author(s):  
Shivananda Manohar J. ◽  
Arpit Koolwal ◽  
T. S. Sathyanarayana Rao

Sexual dysfunction is one of the more common features of depressive disorders, presenting with dysfunction across sexual response cycle. Variety of factors play a role in causing sexual dysfunction in these patients, such as psychological, biological, social and interpersonal factors. Another cause of sexual dysfunction in these patients can be the side effect of antidepressants making it difficult to conclude if the dysfunction is the result of the depression or the treatment of depression. Clinicians need to be aware about the sexual dysfunction as it can have big impact on the overall quality of life of an individual.


Sign in / Sign up

Export Citation Format

Share Document